Results

Total Results: 503 records

Showing results for "breast".
Users also searched for: breast cancer

  1. effectivehealthcare.ahrq.gov/products/retention-strategies-opioid-use-disorder/www.ncbi.nlm.nih.gov/pubmed
    September 23, 2021 - of Telemedicine for Routine Antenatal Care Research Protocol August 6, 2021 Breast … Pharmacologic Interventions Systematic Review April 15, 2021 Accelerated Partial Breast … Irradiation for Breast Cancer Key Questions Draft April 14, 2021 Improving Pain
  2. effectivehealthcare.ahrq.gov/products/retention-strategies-opioid-use-disorder/www.ncbi.nlm.nih.gov
    September 23, 2021 - of Telemedicine for Routine Antenatal Care Research Protocol August 6, 2021 Breast … Pharmacologic Interventions Systematic Review April 15, 2021 Accelerated Partial Breast … Irradiation for Breast Cancer Key Questions Draft April 14, 2021 Improving Pain
  3. effectivehealthcare.ahrq.gov/products/insulin-blood-sugar-2010/sites/default/files/pdf
    September 23, 2021 - of Telemedicine for Routine Antenatal Care Research Protocol August 6, 2021 Breast … Pharmacologic Interventions Systematic Review April 15, 2021 Accelerated Partial Breast … Irradiation for Breast Cancer Key Questions Draft April 14, 2021 Improving Pain
  4. effectivehealthcare.ahrq.gov/products/dcis-effectiveness/abstract
    June 21, 2011 - Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in
  5. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/genitourinary-syndrome-key-questions.pdf
    January 01, 2021 - Safety outcomes, adverse events, adverse systemic events Potential Effect Modifiers • History of breast … anxiety, quality of life, partner satisfaction Systemic hormone levels KQ3&5: Safety outcomes: breast … cancer, breast cancer recurrence or progression, breast tenderness, cardiovascular risk, endometrial … Systemic adverse events: chronic pain, CVA (stroke); VTE (DVT); death; hot flashes; headache; breast … Treatment of Urogenital Symptoms in Individuals With a History of Estrogen- dependent Breast Cancer:
  6. effectivehealthcare.ahrq.gov/products/stakeholders-engagement-others/research
    October 13, 2011 - Amy Bonoff is a 14-year breast cancer survivor and an active and experienced National Breast Cancer … the NBCC Quality Care Advocate Advisory Committee, she has participated in the Department of Defense Breast … a recipient of the San Antonio Cancer Symposium Scholarship, 2007, and is a sought-after speaker on breast
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-topics_methods.pdf
    July 01, 2012 - PET may play an adjunctive role to breast examination and mammography in detecting breast cancer and … Among individuals with localized breast cancer, some may have equivocal results for HER2 protein … Among patients with a palpable breast mass or suspicious mammogram, if FDG PET is performed before … HER2 Testing to Manage Patients With Breast Cancer or Other Solid Tumors. … Should FDG PET be used to decide whether a patient with an abnormal mammogram or breast finding at
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause_disposition-comments.pdf
    March 05, 2015 - Some of the trials including breast cancer patients also included patients who did not have breast … However, hot flushes among breast cancer survivors can be more frequent and more severe. … , and saying the report excluded studies in breast cancer survivors. … for women with and without breast cancer. … See “Executive Summary” comment #3 regarding exclusion of women with breast cancer.
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-key-question.pdf
    September 18, 2023 - are only four cancers recommended for screening by the US Preventive Services Task Force (USPSTF; breast … An economic model published in August 2023 found that USPSTF-recommended cancer screenings for breast … Cancers with gold standard and routine screening modalities (i.e., breast, cervical, and colon cancers … Role of ctDNA in breast cancer. Cancers. 2022;14(2):310. 7.
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_executive.pdf
    June 01, 2013 - outcomes, overall 5-year survival is only 42 percent for ovarian cancer compared with 88 percent for breast … 3 KQ 5: What are the harms of OC use, including breast cancer incidence, cervical cancer incidence … Analytic framework for systematic review BRCA = breast cancer genetic mutation; KQ = Key Question; OC … Harms of OC Use Breast Cancer Table E shows the strength of evidence for the effect of OC use on breast … Ever use of OCs is associated with a small but significant increase in breast cancer risk, based on
  11. effectivehealthcare.ahrq.gov/sites/default/files/hawley-presentation.pdf
    November 11, 2015 - now for decades -­-­ that  African-­American  women  tend  to  be diagnosed  with  later stages of breast … The  next two  studies are  more  my area  of breast cancer research. … This slide  for colorectal cancer patients and  the  next for breast cancer patients, show responses … In  this study we  asked  patients, after they had  completed  their breast cancer treatment, "How … We  were  able  to  examine  this in  our breast cancer sample.
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-210-breastfeeding-disposition-comments.pdf
    January 01, 2020 - ” in contrast to those fed expressed breast milk. … For overall breast cancer, there was only 1 recent SR. … Summary of key findings for Breast cancer, and related tables. … For overall breast cancer, there was only 1 recent SR. … milk from the breast, even one time.
  13. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/research-gaps-womens-health-22.pdf
    April 01, 2022 - mastectomy for breast cancer (or breast cancer prophylaxis). … AR) is probably associated with clinically better sexual well-being and patient satisfaction with breasts … IBR may also pose a greater risk of breast seroma. … • Silicone or saline implants may result in clinically comparable patient satisfaction with breasts … perforator (DIEP) or latissimus dorsi (LD) flaps may result in comparable patient satisfaction with breasts
  14. effectivehealthcare.ahrq.gov/get-involved/nominated-topics/
    August 23, 2021 - Therapy for Bone Metastases Submitted: July 17, 2020 Accelerated Partial Breast … Irradiation for Breast Cancer Submitted: July 17, 2020 Impact of Insurance
  15. S23 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s23.pdf
    October 01, 2007 - Benign breast disease—the risks of commu- nicating risk �comments�. … Collaborative Group on Hormonal Factors in Breast Cancer. … studies of 52,705 women with breast cancer and 108,411 women without breast cancer. … The small risk of breast cancer and possible cardiovascular problems? … She was not happy with the risk of breast cancer, but it sounded small.
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause-protocol-130612.pdf
    June 12, 2013 - Women with breast cancer are excluded. … The issue of tamoxifen use was raised with respect to women with breast cancer. … Given that women with breast cancer are not an included population, this was not further Source: … Given the natural history of osteoporosis—as well as breast, ovarian, and colorectal cancer— a minimum … Women with breast cancer are excluded.
  17. Hi Les, (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/rtc-design-principles_research.pdf
    January 01, 2009 - Example: MRI as an add-on test for staging early breast cancer Breast MRI is proposed to detect additional … for breast-conserving surgery (BCS) (Table 1). … These concepts can be applied to the breast MRI example. … Early Breast Cancer Trialists' Collaborative Group. … Standard for breast conservation therapy in the management of invasive breast carcinoma.
  18. effectivehealthcare.ahrq.gov/products/menopause/research-protocol
    April 03, 2012 - Women with breast cancer are excluded. … The issue of tamoxifen use was raised with respect to women with breast cancer. … Given that women with breast cancer are not an included population, this was not further considered. … Given the natural history of osteoporosis—as well as breast, ovarian, and colorectal cancer—a minimum … Women with breast cancer are excluded.
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/menopause_research-protocol.pdf
    March 25, 2012 - Women with breast cancer are excluded. … The issue of tamoxifen use was raised with respect to women with breast cancer. … Given that women with breast cancer are not an included population, this was not further considered. … Given the natural history of osteoporosis—as well as breast, ovarian, and colorectal cancer— a minimum … Women with breast cancer are excluded.
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-frameworks.ppt
    June 01, 2012 - HER2 testing to manage patients with breast cancer or other solid tumors. … HER2 testing to manage patients with breast cancer or other solid tumors. … HER2 testing to manage patients with breast cancer or other solid tumors. … HER2 testing to manage patients with breast cancer or other solid tumors. … HER2 testing to manage patients with breast cancer or other solid tumors.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: